Type of security: Stock
Sector: Health Care
Industry: Medical Specialities
The data is delayed by 15 minutes.
Description: Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. In addition, it provides molecular diagnostic products in various segments, such as HIV-1 drug resistance testing under the ViroSeq brand name; and reproductive genetics and transplantation under the
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||-95.95%||EPS Growth - Q/Q||-97.76%|
|EPS Growth - Y/Y||-46.52%||Sales Growth - 4 Quarters||-3.31%||Sales Growth - Q/Q||-2.34%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||4.83%||ROE||12.09%||ROI||6.04%|
|Current Ratio||1.14||Quick Ratio||1.09||Long Term Debt/Equity||12.9||Debt Ratio||0.49|
|Gross Margin||37.58%||Operating Margin||13.32%||Net Profit Margin||6.81%||Dividend Payout Ratio||-44.83%|
|Cash From Financing Activities||-246 M||Cash From Investing Activities||-123 M||Cash From Operating Activities||327 M||Gross Profit||747 M|
|Net Profit||118 M||Operating Profit||301 M||Total Assets||9.72 B||Total Current Assets||1.53 B|
|Total Current Liabilities||1.24 B||Total Debt||3.74 B||Total Liabilities||5.41 B||Total Revenue||1.93 B|
|High 52 week||114.44||Low 52 week||79.25||Last close||87.19||Last change||-0.69%|
|RSI||47.59||Average true range||1.98||Beta||0.67||Volume||278.29 K|
|Simple moving average 20 days||-0.69%||Simple moving average 50 days||2.13%||Simple moving average 200 days||-12.16%|
|Performance Week||-0.71%||Performance Month||1.86%||Performance Quart||-7.29%||Performance Half||-20.86%|
|Performance Year||-12.71%||Performance Year-to-date||5.37%||Volatility daily||1.48%||Volatility weekly||3.31%|
|Volatility monthly||6.78%||Volatility yearly||23.5%||Relative Volume||285.51%||Average Volume||1.42 M|
|New High||New Low|
2019-03-16 09:30:01 | Quest Diagnostics DGX Up 3.5% Since Last Earnings Report: Can It Continue?
2019-03-14 09:40:01 | Should Value Investors Pick Quest Diagnostics DGX Stock?
2019-03-12 10:25:31 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
2019-03-11 23:17:52 | Oxford Immunotec Global PLC OXFD Q4 2018 Earnings Conference Call Transcript
2019-03-07 17:30:00 | Quest Diagnostics Prices $500 Million of Senior Notes
2019-03-07 11:28:00 | Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
2019-03-05 07:35:12 | Quest Diagnostics Ties Up With RMC to Deliver Lab Services
2019-03-04 09:28:18 | Should Quest Diagnostics Be Disappointed With Their 64% Profit?
2019-03-01 16:30:00 | Quest Diagnostics Declares Quarterly Cash Dividend
2019-02-27 06:45:00 | RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services
2019-02-22 10:44:03 | Quest Diagnostics Grows on Innovation Amid Reimbursement Woe
2019-02-22 07:25:00 | Analysis: Positioning to Benefit within Quest Diagnostics, Autodesk, Agios Pharmaceuticals, AMN Healthcare Services, Vistra Energy, and Helen of Troy — Research Highlights Growth, Revenue, and Consolidated Results
2019-02-21 16:48:30 | Quest Diagnostics Inc DGX Files 10-K for the Fiscal Year Ended on December 31, 2018
2019-02-19 16:43:00 | Quest Diagnostics Elects Denise Morrison to Board of Directors
2019-02-19 11:42:50 | Edited Transcript of DGX earnings conference call or presentation 14-Feb-19 1:30pm GMT
2019-02-18 08:43:13 | How Much Are Quest Diagnostics Incorporated NYSE:DGX Insiders Taking Off The Table?
2019-02-14 15:37:38 | Quest Diagnostics Inc DGX Q4 2018 Earnings Conference Call Transcript
2019-02-14 13:54:06 | Quest Diagnostics DGX Q4 Earnings in Line, Margins Down
2019-02-14 08:00:01 | Quest Diagnostics DGX Q4 Earnings Meet Estimates
2019-02-14 07:11:15 | Quest Diagnostics: 4Q Earnings Snapshot
2019-02-13 17:20:00 | Quest Diagnostics Expected to Earn $1.37 a Share
2019-02-12 07:29:20 | Quest Diagnostics Reports Earnings in Recovery Mode
2019-02-11 09:19:02 | Can M&A Activity Drive Quest Diagnostics DGX Q4 Earnings?
2019-02-08 08:01:28 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
2019-02-07 10:31:03 | Earnings Preview: Quest Diagnostics DGX Q4 Earnings Expected to Decline
2019-01-31 07:25:00 | Investor Expectations to Drive Momentum within Old Republic International, Quest Diagnostics, Prudential Financial, The Mosaic, PACCAR, and NEXEO SOLUTIONS — Discovering Underlying Factors of Influence
2019-01-29 12:40:50 | Risk-Reward With Quest Diagnostics
2019-01-28 14:28:27 | One Factor To Consider Before Investing In Quest Diagnostics Incorporated NYSE:DGX
2019-01-24 16:48:09 | Quest Diagnostics CEO Steve Rusckowski speaks with Yahoo Finance at Davos 2019
2019-01-24 10:18:32 | Health care CEO: 'Most people don't understand the basic economics' of health care
2019-01-22 08:01:18 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
2019-01-21 10:02:03 | Quest Diagnostics' Core Diagnostics Strong Amid Several Woes
2019-01-15 08:01:12 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
2019-01-09 08:00:34 | See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
2019-01-09 06:55:32 | Is Quest Diagnostics Incorporated’s NYSE:DGX 17% ROE Strong Compared To Its Industry?
2019-01-08 08:20:52 | Health care continues to grow: Quest Diagnostics CEO
2019-01-02 17:27:00 | Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference
2018-12-24 08:14:01 | Quest Diagnostics DGX Divests India Business to Strand
2018-12-22 09:49:58 | Should You Investigate Quest Diagnostics Incorporated NYSE:DGX At US$81.70?